Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/25 17:35 | 6/9/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Quart Barry D | X0 | D | 1 | S.dm | -833 | 30.35 | 0 | -27 | 13 | D | ||||||||||||||||
6/11/25 17:32 | 6/9/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 12 | S.dm | -5,733 | 25.09 | 0 | -228 | 123 | D | |||||||||||||||
6/5/25 16:50 | 6/3/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Megna Michael R | X0 | O | CHIEF AC | 5 | S.dm | -1,624 | 24.86 | 0 | -65 | 33 | D | |||||||||||||||
6/5/25 16:46 | 6/3/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Moat Ross | X0 | O | CHIEF CO | 5 | S.dm | -5,509 | 26.02 | 0 | -212 | 22 | D | |||||||||||||||
6/5/25 16:38 | 6/3/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 8 | S.dm | -6,040 | 24.50 | 0 | -247 | 27 | D | |||||||||||||||
5/28/25 17:25 | 5/23/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Patel Sanj K | X0 | DO | CB,CEO | 8 | S.dm | -10,019 | 24.52 | 0 | -409 | 227 | D | |||||||||||||||
5/9/25 17:01 | 5/7/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Paolini John F. | X0 | O | CHIEF ME | 5 | S.d | -2,793 | 24.96 | 0 | -112 | 57 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |